A Double-blind, Randomised, Placebo-controlled Study of the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Oral Doses of V81444 in Healthy Male Volunteers.

Trial Profile

A Double-blind, Randomised, Placebo-controlled Study of the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Oral Doses of V81444 in Healthy Male Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Sep 2013

At a glance

  • Drugs CPI 444 (Primary)
  • Indications Parkinson's disease
  • Focus Adverse reactions
  • Sponsors Vernalis
  • Most Recent Events

    • 09 Jul 2012 Additional lead trial investigator (Steve Warrington) identified, official title amended and actual patient number is 49 as reported by ClinicalTrials.gov.
    • 09 Jul 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT01634568).
    • 02 May 2012 Results from this trial were presented, according to a Vernalis media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top